High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma

References

• Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(4):504–535. doi:10.6004/jnccn.2017.0050
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
   PubMed Web of Science ®Google Scholar
• Zhu K, Xu A, Xia W, et al. Association between NAT2 polymorphism and lung cancer risk: a systematic review and meta-analysis. Front Oncol. 2021;11:567762. doi:10.3389/fonc.2021.567762
   PubMed Web of Science ®Google Scholar
• Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22. doi:10.1016/j.lungcan.2014.01.009
   PubMed Web of Science ®Google Scholar
• Cheng TY, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME. The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics. J Thorac Oncol. 2016;11(10):1653–1671. doi:10.1016/j.jtho.2016.05.021
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: non-small cell lung cancer, version 1.2020. J Natl Compr Cancer Netw. 2019;17(12):1464–1472. doi:10.6004/jnccn.2019.0059
   PubMed Web of Science ®Google Scholar
• Vargas AJ, Harris CC. Biomarker development in the precision medicine era: lung cancer as a case study. Nature reviews. Cancer. 2016;16(8):525–537. doi:10.1038/nrc.2016.56
   PubMed Web of Science ®Google Scholar
• Zhang B, Xu A, Wu D, et al. ARL14 as a prognostic biomarker in non-small cell lung cancer. J Inflamm Res. 2021;14:6557–6574. doi:10.2147/jir.S340119
   PubMed Web of Science ®Google Scholar
• Liu X, Li T, Huang X, et al. DEPDC1B promotes migration and invasion in pancreatic ductal adenocarcinoma by activating the Akt/GSK3β/Snail pathway. Oncol Lett. 2020;20(5):146. doi:10.3892/ol.2020.12009
   PubMed Web of Science ®Google Scholar
• Garcia-Mata R. Arrested detachment: a DEPDC1B-mediated de-adhesion mitotic checkpoint. Dev Cell. 2014;31(4):387–389. doi:10.1016/j.devcel.2014.11.008
   PubMed Web of Science ®Google Scholar
• Ballon DR, Flanary PL, Gladue DP, Konopka JB, Dohlman HG, Thorner J. DEP-domain-mediated regulation of GPCR signaling responses. Cell. 2006;126(6):1079–1093. doi:10.1016/j.cell.2006.07.030
   PubMed Web of Science ®Google Scholar
• Marchesi S, Montani F, Deflorian G, et al. DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis. Dev Cell. 2014;31(4):420–433. doi:10.1016/j.devcel.2014.09.009
   PubMed Web of Science ®Google Scholar
• Chen D, Ito S, Hyodo T, Asano-Inami E, Yuan H, Senga T. Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis. Exp Cell Res. 2017;358(2):101–110. doi:10.1016/j.yexcr.2017.06.005
   PubMed Web of Science ®Google Scholar
• Bai S, Chen T, Du T, et al. High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer. Oncol Lett. 2017;14(6):6801–6808. doi:10.3892/ol.2017.7027
   PubMed Web of Science ®Google Scholar
• Chen X, Guo ZQ, Cao D, Chen Y, Chen J. Knockdown of DEPDC1B inhibits the development of glioblastoma. Cancer Cell Int. 2020;20:310. doi:10.1186/s12935-020-01404-7
   PubMed Web of Science ®Google Scholar
• Dang XW, Pan Q, Lin ZH, et al. Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1. Aging. 2021;13(16):20094–20115. doi:10.18632/aging.203016
   PubMedGoogle Scholar
• Lai CH, Xu K, Zhou J, et al. DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1. Cell Death Dis. 2020;11(11):986. doi:10.1038/s41419-020-03190-6
   PubMed Web of Science ®Google Scholar
• Zhang S, Shi W, Hu W, et al. DEP domain-containing protein 1B (DEPDC1B) promotes migration and invasion in pancreatic cancer through the Rac1/PAK1-LIMK1-Cofilin1 signaling pathway. Onco Targets Ther. 2020;13:1481–1496. doi:10.2147/ott.S229055
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(7):990–1003. doi:10.1097/jto.0000000000000559
   PubMed Web of Science ®Google Scholar
• Li Q, Wu J, Wei P, et al. Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition. Am J Cancer Res. 2015;5(6):2022–2034.
   PubMed Web of Science ®Google Scholar
• Dalman MR, Deeter A, Nimishakavi G, Duan ZH. Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinform. 2012;13(Suppl 2):S11. doi:10.1186/1471-2105-13-s2-s11
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi:10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Jiang H, Xu A, Xia W, et al. Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis. Cancer Cell Int. 2021;21(1):426. doi:10.1186/s12935-021-02100-w
   PubMed Web of Science ®Google Scholar
• Zhang B, Liu Y, Zhou S, Jiang H, Zhu K, Wang R. Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: a meta-analysis. Int Immunopharmacol. 2020;80:106214. doi:10.1016/j.intimp.2020.106214
   PubMed Web of Science ®Google Scholar
• Liao Z, Wang X, Zeng Y, Zou Q. Identification of DEP domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues. Sci Rep. 2016;6:39655. doi:10.1038/srep39655
   PubMed Web of Science ®Google Scholar
• Ahuja P, Singh K. In Silico Approach for SAR analysis of the predicted model of DEPDC1B: a novel target for oral cancer. Adv Bioinformatics. 2016;2016:3136024. doi:10.1155/2016/3136024
   PubMedGoogle Scholar
• Gu Y, Li J, Guo D, et al. Identification of 13 key genes correlated with progression and prognosis in hepatocellular carcinoma by weighted gene co-expression network analysis. Front Genet. 2020;11:153. doi:10.3389/fgene.2020.00153
   PubMed Web of Science ®Google Scholar
• Li Z, Wang Q, Peng S, et al. The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling. Clin Transl Med. 2020;10(6):e191. doi:10.1002/ctm2.191
   PubMed Web of Science ®Google Scholar
• Xu Y, Sun W, Zheng B, et al. DEPDC1B knockdown inhibits the development of malignant melanoma through suppressing cell proliferation and inducing cell apoptosis. Exp Cell Res. 2019;379(1):48–54. doi:10.1016/j.yexcr.2019.03.021
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu L, Cai J, et al. DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling. Biochem Biophys Res Commun. 2014;450(1):899–905. doi:10.1016/j.bbrc.2014.06.076
   PubMed Web of Science ®Google Scholar
• Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461–1473. doi:10.1038/onc.2016.304
   PubMed Web of Science ®Google Scholar
• Clevers H, Loh KM, Nusse R. Stem cell signaling. An integral program for tissue renewal and regeneration: wnt signaling and stem cell control. Science. 2014;346(6205):1248012. doi:10.1126/science.1248012
   PubMed Web of Science ®Google Scholar
• Campbell JD, Alexandrov A, Kim J, et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet. 2016;48(6):607–616. doi:10.1038/ng.3564
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Stankovic B, Bjørhovde HA, Skarshaug R, et al. Immune cell composition in human non-small cell lung cancer. Front Immunol. 2018;9:3101. doi:10.3389/fimmu.2018.03101
   PubMed Web of Science ®Google Scholar
• Anichini A, Perotti VE, Sgambelluri F, Mortarini R. Immune escape mechanisms in non small cell lung cancer. Cancers. 2020;12(12):3605. doi:10.3390/cancers12123605
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Jin C, Lagoudas GK, Zhao C, et al. Commensal microbiota promote lung cancer development via γδ T cells. Cell. 2019;176(5):998–1013.e16. doi:10.1016/j.cell.2018.12.040
   PubMed Web of Science ®Google Scholar
• Story JY, Zoine JT, Burnham RE, et al. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia. Cytotherapy. 2021;23(1):12–24. doi:10.1016/j.jcyt.2020.09.010
   PubMed Web of Science ®Google Scholar
• Faustino LD, Griffith JW, Rahimi RA, et al. Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung. Nat Immunol. 2020;21(11):1371–1383. doi:10.1038/s41590-020-0785-3
   PubMed Web of Science ®Google Scholar
• Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med. 2008;358(17):1860–1861. doi:10.1056/NEJMcibr0801519
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brünner N, Moesgaard F. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol. 1999;189(4):487–495. doi:10.1002/(sici)1096-9896(199912)189:4<487::Aid-path484>3.0.Co;2-i
   PubMed Web of Science ®Google Scholar
• Davis BP, Rothenberg ME. Eosinophils and cancer. Cancer Immunol Res. 2014;2(1):1–8. doi:10.1158/2326-6066
   PubMed Web of Science ®Google Scholar